1 Min Read
April 3 (Reuters) - Intelgenx Technologies Corp:
* Intelgenx and Tetra Bio-Pharma announce the signing of a definitive agreement for the development and commercialization of a dronabinol xl tablet Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.